Titre : Vascularite

Vascularite : Questions médicales fréquentes

Termes MeSH sélectionnés :

Voice

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une vascularite ?

Le diagnostic repose sur des analyses sanguines, des biopsies et des examens d'imagerie.
Vascularite Biopsie Imagerie médicale
#2

Quels tests sanguins sont utilisés ?

Des tests comme la vitesse de sédimentation et les marqueurs inflammatoires sont courants.
Tests sanguins Inflammation Vitesse de sédimentation
#3

Quels symptômes indiquent une vascularite ?

Symptômes incluent fatigue, fièvre, douleurs articulaires et éruptions cutanées.
Symptômes Fatigue Éruption cutanée
#4

La biopsie est-elle toujours nécessaire ?

Non, elle est souvent utilisée si les tests sanguins ne sont pas concluants.
Biopsie Diagnostic Vascularite
#5

Quels spécialistes consultent pour une vascularite ?

Les rhumatologues et les médecins internistes sont souvent impliqués dans le diagnostic.
Rhumatologie Médecine interne Vascularite

Symptômes 5

#1

Quels sont les symptômes courants de la vascularite ?

Les symptômes incluent fatigue, fièvre, douleurs musculaires et éruptions cutanées.
Symptômes Fatigue Éruption cutanée
#2

La vascularite peut-elle causer des douleurs articulaires ?

Oui, les douleurs articulaires sont fréquentes et peuvent être sévères.
Douleurs articulaires Vascularite Symptômes
#3

Y a-t-il des symptômes neurologiques associés ?

Oui, des maux de tête, des troubles de la vision et des engourdissements peuvent survenir.
Symptômes neurologiques Vascularite Engourdissement
#4

Les éruptions cutanées sont-elles spécifiques ?

Elles peuvent varier, mais souvent apparaissent sous forme de plaques ou de purpura.
Éruption cutanée Purpura Vascularite
#5

La vascularite peut-elle affecter les organes internes ?

Oui, elle peut toucher les reins, les poumons et le cœur, entraînant des complications.
Organes internes Complications Vascularite

Prévention 5

#1

Peut-on prévenir la vascularite ?

Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide.
Prévention Suivi médical Vascularite
#2

Les vaccinations sont-elles recommandées ?

Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent la vascularite.
Vaccination Prévention Infections
#3

Comment éviter les déclencheurs ?

Éviter le tabac, le stress et les infections peut réduire les risques de poussées.
Déclencheurs Prévention Vascularite
#4

Le suivi médical est-il important ?

Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes.
Suivi médical Vascularite Traitement
#5

Y a-t-il des conseils diététiques ?

Une alimentation équilibrée et riche en antioxydants peut soutenir la santé vasculaire.
Alimentation Antioxydants Vascularite

Traitements 5

#1

Quels traitements sont disponibles pour la vascularite ?

Les corticostéroïdes et les immunosuppresseurs sont couramment utilisés.
Corticostéroïdes Immunosuppresseurs Traitement
#2

Les corticostéroïdes sont-ils efficaces ?

Oui, ils réduisent l'inflammation et soulagent les symptômes rapidement.
Corticostéroïdes Inflammation Vascularite
#3

Quand utilise-t-on des immunosuppresseurs ?

Ils sont utilisés pour les cas graves ou réfractaires aux corticostéroïdes.
Immunosuppresseurs Vascularite Traitement
#4

Y a-t-il des traitements alternatifs ?

Des thérapies biologiques peuvent être envisagées dans certains cas spécifiques.
Thérapies biologiques Vascularite Traitement
#5

Le traitement est-il à long terme ?

Cela dépend de la gravité et de la réponse au traitement, souvent plusieurs mois.
Traitement Vascularite Suivi médical

Complications 5

#1

Quelles sont les complications possibles de la vascularite ?

Les complications incluent des lésions organiques, des AVC et des problèmes cardiaques.
Complications Lésions organiques Vascularite
#2

La vascularite peut-elle entraîner des problèmes rénaux ?

Oui, elle peut causer une insuffisance rénale aiguë ou chronique.
Insuffisance rénale Complications Vascularite
#3

Quels risques cardiovasculaires sont associés ?

Les patients peuvent avoir un risque accru de maladies cardiaques et d'AVC.
Risques cardiovasculaires AVC Vascularite
#4

Les complications sont-elles réversibles ?

Certaines complications peuvent être réversibles avec un traitement précoce.
Complications Traitement Vascularite
#5

Comment surveiller les complications ?

Des examens réguliers et des tests de fonction organique sont essentiels.
Surveillance Examens médicaux Vascularite

Facteurs de risque 5

#1

Quels sont les facteurs de risque de la vascularite ?

Les facteurs incluent des antécédents familiaux, des infections et certains médicaments.
Facteurs de risque Antécédents familiaux Vascularite
#2

L'âge influence-t-il le risque de vascularite ?

Oui, certaines formes de vascularite sont plus fréquentes chez les personnes âgées.
Âge Facteurs de risque Vascularite
#3

Les infections peuvent-elles déclencher une vascularite ?

Oui, des infections virales ou bactériennes peuvent être des déclencheurs.
Infections Déclencheurs Vascularite
#4

Le tabagisme est-il un facteur de risque ?

Oui, le tabagisme est associé à un risque accru de vascularite.
Tabagisme Facteurs de risque Vascularite
#5

Certaines maladies auto-immunes augmentent-elles le risque ?

Oui, des maladies comme le lupus ou la polyarthrite rhumatoïde sont des facteurs de risque.
Maladies auto-immunes Facteurs de risque Vascularite
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vascularite : Questions médicales les plus fréquentes", "headline": "Vascularite : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vascularite : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-06", "dateModified": "2025-03-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vascularite" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies vasculaires", "url": "https://questionsmedicales.fr/mesh/D014652", "about": { "@type": "MedicalCondition", "name": "Maladies vasculaires", "code": { "@type": "MedicalCode", "code": "D014652", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aortite", "alternateName": "Aortitis", "url": "https://questionsmedicales.fr/mesh/D001025", "about": { "@type": "MedicalCondition", "name": "Aortite", "code": { "@type": "MedicalCode", "code": "D001025", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.080" } } }, { "@type": "MedicalWebPage", "name": "Artérite", "alternateName": "Arteritis", "url": "https://questionsmedicales.fr/mesh/D001167", "about": { "@type": "MedicalCondition", "name": "Artérite", "code": { "@type": "MedicalCode", "code": "D001167", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.090" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Endartérite", "alternateName": "Endarteritis", "url": "https://questionsmedicales.fr/mesh/D004692", "about": { "@type": "MedicalCondition", "name": "Endartérite", "code": { "@type": "MedicalCode", "code": "D004692", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.090.340" } } } ] }, { "@type": "MedicalWebPage", "name": "Syndrome de Cogan", "alternateName": "Cogan Syndrome", "url": "https://questionsmedicales.fr/mesh/D055952", "about": { "@type": "MedicalCondition", "name": "Syndrome de Cogan", "code": { "@type": "MedicalCode", "code": "D055952", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.320" } } }, { "@type": "MedicalWebPage", "name": "Phlébite", "alternateName": "Phlebitis", "url": "https://questionsmedicales.fr/mesh/D010689", "about": { "@type": "MedicalCondition", "name": "Phlébite", "code": { "@type": "MedicalCode", "code": "D010689", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.740" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thrombophlébite", "alternateName": "Thrombophlebitis", "url": "https://questionsmedicales.fr/mesh/D013924", "about": { "@type": "MedicalCondition", "name": "Thrombophlébite", "code": { "@type": "MedicalCode", "code": "D013924", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.740.910" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome de Lemierre", "alternateName": "Lemierre Syndrome", "url": "https://questionsmedicales.fr/mesh/D057831", "about": { "@type": "MedicalCondition", "name": "Syndrome de Lemierre", "code": { "@type": "MedicalCode", "code": "D057831", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.740.910.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Syndrome de Lemierre", "alternateName": "Lemierre Syndrome", "url": "https://questionsmedicales.fr/mesh/D057831", "about": { "@type": "MedicalCondition", "name": "Syndrome de Lemierre", "code": { "@type": "MedicalCode", "code": "D057831", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.740.910.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Vascularite rétinienne", "alternateName": "Retinal Vasculitis", "url": "https://questionsmedicales.fr/mesh/D031300", "about": { "@type": "MedicalCondition", "name": "Vascularite rétinienne", "code": { "@type": "MedicalCode", "code": "D031300", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.815" } } }, { "@type": "MedicalWebPage", "name": "Vascularite systémique", "alternateName": "Systemic Vasculitis", "url": "https://questionsmedicales.fr/mesh/D056647", "about": { "@type": "MedicalCondition", "name": "Vascularite systémique", "code": { "@type": "MedicalCode", "code": "D056647", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.897" } } }, { "@type": "MedicalWebPage", "name": "Thromboangéite oblitérante", "alternateName": "Thromboangiitis Obliterans", "url": "https://questionsmedicales.fr/mesh/D013919", "about": { "@type": "MedicalCondition", "name": "Thromboangéite oblitérante", "code": { "@type": "MedicalCode", "code": "D013919", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.940.905" } } } ], "about": { "@type": "MedicalCondition", "name": "Vascularite", "alternateName": "Vasculitis", "code": { "@type": "MedicalCode", "code": "D014657", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "David S Younger", "url": "https://questionsmedicales.fr/author/David%20S%20Younger", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu." } }, { "@type": "Person", "name": "Tanaz A Kermani", "url": "https://questionsmedicales.fr/author/Tanaz%20A%20Kermani", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA." } }, { "@type": "Person", "name": "Christian Pagnoux", "url": "https://questionsmedicales.fr/author/Christian%20Pagnoux", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto." } }, { "@type": "Person", "name": "Cristina Ponte", "url": "https://questionsmedicales.fr/author/Cristina%20Ponte", "affiliation": { "@type": "Organization", "name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com." } }, { "@type": "Person", "name": "Nikita Khmelinskii", "url": "https://questionsmedicales.fr/author/Nikita%20Khmelinskii", "affiliation": { "@type": "Organization", "name": "Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Effects of Cognitive Stress on Voice Acoustics in Individuals With Hyperfunctional Voice Disorders.", "datePublished": "2022-12-14", "url": "https://questionsmedicales.fr/article/36516470", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_AJSLP-22-00204" } }, { "@type": "ScholarlyArticle", "name": "Changes in positive and negative voice content in cognitive-behavioural therapy for distressing voices.", "datePublished": "2022-05-06", "url": "https://questionsmedicales.fr/article/35523677", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/papt.12399" } }, { "@type": "ScholarlyArticle", "name": "'Is there something wrong with your voice?' A qualitative study of the voice concerns of people with laryngotracheal stenosis.", "datePublished": "2022-10-03", "url": "https://questionsmedicales.fr/article/36189991", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/1460-6984.12794" } }, { "@type": "ScholarlyArticle", "name": "The acceptance and voice quality of a new voice prosthesis 'Vega High performance' - a feasibility study.", "datePublished": "2023-09-01", "url": "https://questionsmedicales.fr/article/37656679", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/00016489.2023.2241876" } }, { "@type": "ScholarlyArticle", "name": "Exploring Motives and Perceived Barriers for Voice Modification: The Views of Transgender and Gender-Diverse Voice Clients.", "datePublished": "2023-06-01", "url": "https://questionsmedicales.fr/article/37263019", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2023_JSLHR-23-00042" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Vascularite", "item": "https://questionsmedicales.fr/mesh/D014657" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vascularite - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vascularite", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vascularite", "description": "Comment diagnostiquer une vascularite ?\nQuels tests sanguins sont utilisés ?\nQuels symptômes indiquent une vascularite ?\nLa biopsie est-elle toujours nécessaire ?\nQuels spécialistes consultent pour une vascularite ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Voice#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vascularite", "description": "Quels sont les symptômes courants de la vascularite ?\nLa vascularite peut-elle causer des douleurs articulaires ?\nY a-t-il des symptômes neurologiques associés ?\nLes éruptions cutanées sont-elles spécifiques ?\nLa vascularite peut-elle affecter les organes internes ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Voice#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vascularite", "description": "Peut-on prévenir la vascularite ?\nLes vaccinations sont-elles recommandées ?\nComment éviter les déclencheurs ?\nLe suivi médical est-il important ?\nY a-t-il des conseils diététiques ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Voice#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vascularite", "description": "Quels traitements sont disponibles pour la vascularite ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand utilise-t-on des immunosuppresseurs ?\nY a-t-il des traitements alternatifs ?\nLe traitement est-il à long terme ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Voice#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vascularite", "description": "Quelles sont les complications possibles de la vascularite ?\nLa vascularite peut-elle entraîner des problèmes rénaux ?\nQuels risques cardiovasculaires sont associés ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Voice#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vascularite", "description": "Quels sont les facteurs de risque de la vascularite ?\nL'âge influence-t-il le risque de vascularite ?\nLes infections peuvent-elles déclencher une vascularite ?\nLe tabagisme est-il un facteur de risque ?\nCertaines maladies auto-immunes augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D014657?mesh_terms=Voice#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une vascularite ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des analyses sanguines, des biopsies et des examens d'imagerie." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la vitesse de sédimentation et les marqueurs inflammatoires sont courants." } }, { "@type": "Question", "name": "Quels symptômes indiquent une vascularite ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes incluent fatigue, fièvre, douleurs articulaires et éruptions cutanées." } }, { "@type": "Question", "name": "La biopsie est-elle toujours nécessaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle est souvent utilisée si les tests sanguins ne sont pas concluants." } }, { "@type": "Question", "name": "Quels spécialistes consultent pour une vascularite ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les rhumatologues et les médecins internistes sont souvent impliqués dans le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la vascularite ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, fièvre, douleurs musculaires et éruptions cutanées." } }, { "@type": "Question", "name": "La vascularite peut-elle causer des douleurs articulaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les douleurs articulaires sont fréquentes et peuvent être sévères." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maux de tête, des troubles de la vision et des engourdissements peuvent survenir." } }, { "@type": "Question", "name": "Les éruptions cutanées sont-elles spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent varier, mais souvent apparaissent sous forme de plaques ou de purpura." } }, { "@type": "Question", "name": "La vascularite peut-elle affecter les organes internes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut toucher les reins, les poumons et le cœur, entraînant des complications." } }, { "@type": "Question", "name": "Peut-on prévenir la vascularite ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide." } }, { "@type": "Question", "name": "Les vaccinations sont-elles recommandées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent la vascularite." } }, { "@type": "Question", "name": "Comment éviter les déclencheurs ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabac, le stress et les infections peut réduire les risques de poussées." } }, { "@type": "Question", "name": "Le suivi médical est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des conseils diététiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et riche en antioxydants peut soutenir la santé vasculaire." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la vascularite ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes et les immunosuppresseurs sont couramment utilisés." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils réduisent l'inflammation et soulagent les symptômes rapidement." } }, { "@type": "Question", "name": "Quand utilise-t-on des immunosuppresseurs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont utilisés pour les cas graves ou réfractaires aux corticostéroïdes." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies biologiques peuvent être envisagées dans certains cas spécifiques." } }, { "@type": "Question", "name": "Le traitement est-il à long terme ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la gravité et de la réponse au traitement, souvent plusieurs mois." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la vascularite ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions organiques, des AVC et des problèmes cardiaques." } }, { "@type": "Question", "name": "La vascularite peut-elle entraîner des problèmes rénaux ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut causer une insuffisance rénale aiguë ou chronique." } }, { "@type": "Question", "name": "Quels risques cardiovasculaires sont associés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent avoir un risque accru de maladies cardiaques et d'AVC." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement précoce." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers et des tests de fonction organique sont essentiels." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la vascularite ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections et certains médicaments." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de vascularite ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines formes de vascularite sont plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Les infections peuvent-elles déclencher une vascularite ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections virales ou bactériennes peuvent être des déclencheurs." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à un risque accru de vascularite." } }, { "@type": "Question", "name": "Certaines maladies auto-immunes augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le lupus ou la polyarthrite rhumatoïde sont des facteurs de risque." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 03/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

David S Younger

3 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Section of Neuroscience, City University of New York School of Medicine, New York, NY, USA; Department of Neurology, White Plains Hospital, White Plains, NY, USA. Electronic address: youngd01@nyu.edu.
Publications dans "Vascularite" :

Tanaz A Kermani

3 publications dans cette catégorie

Affiliations :
  • Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, USA.
Publications dans "Vascularite" :

Christian Pagnoux

3 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto.
Publications dans "Vascularite" :

Cristina Ponte

2 publications dans cette catégorie

Affiliations :
  • Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
  • Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. cristinadbponte@gmail.com.
Publications dans "Vascularite" :

Nikita Khmelinskii

2 publications dans cette catégorie

Affiliations :
  • Rheumatology Department, Hospital de Santa Maria - Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
  • Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Publications dans "Vascularite" :

Dennis McGonagle

2 publications dans cette catégorie

Affiliations :
  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
  • National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals, Leeds, UK.
Publications dans "Vascularite" :

Elisabeth Brouwer

2 publications dans cette catégorie

Affiliations :
  • University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: e.brouwer@umcg.nl.
Publications dans "Vascularite" :

Seza Ozen

2 publications dans cette catégorie

Affiliations :
  • Division of Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Hacettepe University Vasculitis Research Center, Ankara, Turkey.
Publications dans "Vascularite" :

Paul A Monach

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publications dans "Vascularite" :

Ulrich Specks

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Pulmonary and Critical Care Medicine.
Publications dans "Vascularite" :

Kenneth J Warrington

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
Publications dans "Vascularite" :

Peter A Merkel

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Rheumatology and Division of Clinical Epidemiology, University of Pennsylvania, Philadelphia, PA.
Publications dans "Vascularite" :

None None

2 publications dans cette catégorie

Publications dans "Vascularite" :

Hannah Cooke

2 publications dans cette catégorie

Affiliations :
  • Musgrove Park Hospital, Taunton, UK.

Matthew Wells

2 publications dans cette catégorie

Affiliations :
  • North Bristol Trust, Bristol, UK matthew.wells@nbt.nhs.uk.

Keith Miller

2 publications dans cette catégorie

Affiliations :
  • North Bristol Trust, Bristol, UK.

Andrew R L Medford

2 publications dans cette catégorie

Affiliations :
  • North Bristol Trust, Bristol, UK.

Sam Patel

2 publications dans cette catégorie

Affiliations :
  • North Bristol Trust, Bristol, UK.

Fawad Aslam

2 publications dans cette catégorie

Affiliations :
  • Mayo Clinic, Phoenix, Arizona, USA.

Mario Sestan

2 publications dans cette catégorie

Affiliations :
  • Department of Paediatrics, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.

Sources (2104 au total)

Effects of Cognitive Stress on Voice Acoustics in Individuals With Hyperfunctional Voice Disorders.

Autonomic nervous system dysfunction has been implicated in the development and persistence of hyperfunctional voice disorders (HVDs). The purpose of this study was to determine the effects of cogniti... Adult female speakers-66 with HVDs, 66 without-were recorded while speaking with and without a cognitive stressor. Root-mean-square (RMS) of amplitude, fundamental frequency (... All measures differed significantly under cognitive stress for speakers with and without HVDs. RMS and CPP increased whereas... Cognitive stress and presumed autonomic arousal affect voice similarly in female speakers with and without HVDs....

Changes in positive and negative voice content in cognitive-behavioural therapy for distressing voices.

People who experience distressing voices frequently report negative (e.g. abusive or threatening) voice content and this is a key driver of distress. There has also been recognition that positive (e.g... In a naturalistic, uncontrolled pre- and post- service evaluation study, 32 clients at an outpatient psychology service for distressing voices received eight sessions of CBT for distressing voices and... There was no significant change in positive voice content. There was no significant change in negative voice content from pre- to post-therapy; however, there was a significant change in negative voic... The cognitive component of CBT for distressing voices may be associated with changes in negative, but not positive, voice content. There may be benefit to enhancing these effects by developing treatme...

'Is there something wrong with your voice?' A qualitative study of the voice concerns of people with laryngotracheal stenosis.

Acquired laryngotracheal stenosis (LTS) is a rare condition that causes breathlessness and dyspnoea. Patients have reconstructive airway surgery to improve their breathing difficulties, but both LTS a... To investigate the lived experience of adults with laryngotracheal stenosis (LTS), who have had reconstructive surgery; here focussing on voice concerns with the aim of guiding clinical care for SLTs.... A phenomenological, qualitative study design was used. Focus groups and semi-structured interviews were completed with adults living with LTS who had had reconstructive surgery. Audio recordings were ... A total of 24 participants (five focus groups and two interviews) took part in the study before thematic saturation was identified in analysis. Three main themes were identified specific to the experi... In this qualitative study participants have described the integral part voice difficulties play in their lived experience of LTS and reconstructive surgery. This is considered in the context of their ... What is already known on this subject Adults with laryngotracheal stenosis (LTS) experience voice changes as a result of their condition, and the surgeries necessary as a treatment. These changes can ...

The acceptance and voice quality of a new voice prosthesis 'Vega High performance' - a feasibility study.

The Provox Vega High Performance (PVHP) is a newly developed voice prosthesis (VP) with an aim to achieve a longer and more predictable lifetime.... This feasibility study aims to assess patient acceptance of the PVHP VP, evaluate adverse events, voice quality, and device lifetime.... Laryngectomized patients previously using a Provox Vega or ActiValve Light were included. Acceptance and voice outcomes were evaluated at two-time points with a 2-week interval. Baseline measurements ... Fifteen participants completed the study, with thirteen being initial Vega-users. PVHP acceptance was 87% 2 weeks after placement. Median device lifetime for all VPs was 64 d (range 14-370). In the su... Acceptance of the PVHP is largely dependent on device lifetime, decreasing from 87% to 40% after leakage or replacement. Voice quality remains consistent across different VPs. Developing a long-lastin...

Exploring Motives and Perceived Barriers for Voice Modification: The Views of Transgender and Gender-Diverse Voice Clients.

To date, transgender and gender-diverse voice clients' perceptions and individual goals have been missing in discussions and research on gender-affirming voice therapy. Little is, therefore, known abo... Individual, semistructured interviews with 15 transgender and gender-diverse voice clients considering voice therapy were conducted and explored using qualitative content analysis.... Three themes were identified during the analysis of the participants' narratives. In the first theme, "the incongruent voice setting the rules," the contribution of the voice on the experienced gender... The interviews clearly indicate a need for a person-centered voice therapy that starts from the individuals' expressed motives for modifying the voice yet also are affirmative of anticipated difficult...

The Effect of Vocal Hygiene Education Programs on Voice Quality in Professional Voice Users: A Systematic Review.

This study aimed to critically appraise recent peer-reviewed scientific evidence on the effect of vocal hygiene education on voice quality and function directly and indirectly measured by auditory-per... A systematic review was conducted utilizing the Preferred Reporting Items for Systematic review and Meta-Analyses Protocols (PRISMA-P) guidelines. Five databases were searched using the keywords "voca... Four studies (17%) linked low awareness of vocal hygiene or insufficient vocal hygiene education to self-reported acute and chronic voice symptoms, as well as a greater perception of voice handicap am... Recent literature demonstrates mixed results obtained through auditory-perceptual, acoustic, and self-rating measures on the effects of vocal hygiene instruction on vocal quality and function in profe...

Voice outcome in medialisation thyroplasty with and without arytenoid adduction: a prospective comparison using intraoperative voice measurements.

Arytenoid adduction as an addition to medialisation thyroplasty is highly advocated by some surgeons in selected cases but deemed less necessary by others in patients with unilateral vocal fold paraly... A prospective study was conducted. Voice audio recordings were obtained at 4 moments; 1. direct prior to the start of surgery, 2. during surgery after medialisation thyroplasty, 3. during surgery afte... Ten patients who underwent medialisation and arytenoid adduction at our tertiary referral hospital between 2021 and 2022, were included. One patient was excluded after surgery. The intraoperative meas... Our study using intraoperative voice measurements indicate that the addition of arytenoid adduction to medialisation thyroplasty is a benefit in selected patients although more studies are needed due ...

Voice hearers' explanations of trauma-related voices and processes of change throughout imagery rescripting: A qualitative exploration.

Post-traumatic stress is common among people who hear voices (auditory verbal hallucinations), many of whom hear trauma-related voices, whereby voice content is related to past trauma. Preliminary evi... Thematic analytical methodology was used due to the study's critical epistemological framework.... Semi-structured interviews explored relationships between trauma and voices, and experiences of change and stability throughout ImRs in a transdiagnostic sample (N = 10) who underwent 10-18 weekly ImR... Two themes captured explanations of voices, which suggested voices may have counterproductive protective functions. Three themes captured psychological experiences during ImRs, which reflected concept... Trauma-related voices may have underlying protective functions and ImRs may support emotional expression, adaptive trauma re-appraisals and improve self-worth and coping self-efficacy. These change pr...

Recognizing Voices Through a Cochlear Implant: A Systematic Review of Voice Perception, Talker Discrimination, and Talker Identification.

Some cochlear implant (CI) users report having difficulty accessing indexical information in the speech signal, presumably due to limitations in the transmission of fine spectrotemporal cues. The purp... We completed a systematic search of the literature with select key words using citation aggregation software to search Google Scholar. We included primary reports that tested (a) talker discrimination... The searches resulted in 1,561 references, which were first screened for inclusion and then evaluated in full. Forty-three studies examining talker discrimination, voice perception, and talker identif... The current review highlights the challenges faced by CI users in tracking and recognizing voices and how they adapt to it. Although large variability exists, there is evidence that CI users can proce...